SLC22A1 Antibody (609222) [Janelia Fluor® 669]
Novus Biologicals, part of Bio-Techne | Catalog # FAB6469JF669
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Flow Cytometry, Western Blot
Label
Janelia Fluor 669
Antibody Source
Monoclonal Mouse IgG2A Clone # 609222
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
NS0 mouse myeloma cell line transfected with human SLC22A1
Met1-Thr554
Accession # NP_003048
Met1-Thr554
Accession # NP_003048
Specificity
Detects human SLC22A1 in Western blots.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2A
Applications for SLC22A1 Antibody (609222) [Janelia Fluor® 669]
Application
Recommended Usage
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
0
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: SLC22A1
Long Name
Solute carrier family 22 member 1
Alternate Names
OCT1
Gene Symbol
SLC22A1
Additional SLC22A1 Products
Product Documents for SLC22A1 Antibody (609222) [Janelia Fluor® 669]
Product Specific Notices for SLC22A1 Antibody (609222) [Janelia Fluor® 669]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...